Skip to main content
Equibles
ALMR logo

ALMR · Alamar Biosciences, Inc.

Track ALMR — free

Use ALMR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ALMR

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$34.24 -0.40 (-1.15%) At close · Aug 21
Market Cap
$2.38B
Shares
69.39M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$34.24 Open$34.93 Day$34.14–36.10 Available close range$19.09–36.57 Avg vol 30d300K Short int2.4M · 3.5% float · 11.3d Short vol68% Last earningsAug 10, 2026 DataApr 2026–Aug 2026 Filing10-Q · Aug 11

The closing range uses available history since Apr 17, 2026; less than a full year is stored.

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 11, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Limited Sentiment Neutral Fundamentals Limited Quant / Vol Very High
      Market backdrop VIX 15.1 · calm Equity put/call 0.51
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 50-day avg +28%
      above
      RSI (14) 64
      neutral
      MACD trend Positive
      52-week position 87%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Limited
      Not enough data for a confident read.
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50/200-day averages unavailable
      Institutional flow Accumulating
      +85 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      3.50% of float · ▲ +8.2% MoM · 11.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      85 holders — 13F breadth
      Squeeze score 77
      high risk · 0–100
      Fundamentals
      Limited
      Not enough data for a confident read.
      Quant / Vol
      risk profile
      Very High
      Volatility 84%
      annualized · 1-yr
      Max drawdown −28%
      past year
      ATR 7.3%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 10, 2026
      Full year 2026 revenue · full year 2026 Maintained $116M – $120M
      Jun 30, 2026 $116M – $120M changed to Aug 10, 2026 $116M – $120M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 3 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 50-day avg
      +28% Bullish
      RSI (14)
      64 Neutral
      MACD trend
      Positive Bullish
      52-week position
      87% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50/200-day averages unavailable
      Institutional flow Accumulating
      +85 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      3.50% of float · ▲ +8.2% MoM · 11.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      85 holders — 13F breadth
      Price context
      position in its available closing range
      Range low $19 Now $34 · 87% Range high $37
      vs 50-day avg +28%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Gross margin 60% the second quarter of 2026 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      ALMR
      Alamar Biosciences, Inc.
      this stock
      		$2.38B — — — 3.5%
      ABT
      Abbott Laboratories
      		 $203.17B -6.9% +5.7% 32.7 1.3%
      SYK
      Stryker Corp
      		 $126.37B -6.3% +11.2% 34.1 2.2%
      MDT
      Medtronic plc
      		 $119.49B -2.8% +8.4% 25.0 1.4%
      BSX
      Boston Scientific Corp
      		 $73.00B -47.2% +12.5% 20.4 1.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      85
      % held
      35.1%
      Net QoQ
      +24.4M sh
      Top holder
      Sands Capital Alternative…
      Held Float
      View
      Held by Funds
      Fund positions
      35
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      2.4M
      Days to cover
      11.3d
      Change
      +184.3K sh
      View
      Short Volume
      Short vol %
      68%
      As of
      Aug 21, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1.4K
      Value
      $35.0K
      As of
      Jul 30, 2026
      View
      Off-Exchange
      Off-exchange %
      54.0%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 11, 2026
      This year
      6
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 10, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      ALMR +3.3% +32.3% — +35.0% —
      SPY -1.4% +3.6% +11.6% +2.5% +12.3%
      vs SPY +4.6% +28.7% — +32.5% —
      Key facts CIK 2104204 CUSIP 010911105 13F (30d) 84 filings 84 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)